(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INDEPENDENT PHARMACEUTICAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

INDEPENDENT PHARMACEUTICAL

ST13

US500000086701236

Class

35

Filing

86701236

Registration

5163006

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

03/15/2026

Trademark type

Word

Nice classes

35

Filing date

07/22/2015

Registration date

03/14/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/10/2023

Last transaction

03/15/2026

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

10/11/2013

First use in commerce

10/11/2013

Drawing code

4

Owner type

16

Owner location

Wimberley, TX, US

Examiner

VALLILLO, MELISSA C

Law office

L50

Current location

TMEG LAW OFFICE 105

Holders and representatives

Holders

Independent Pharmaceutical, LLC
Independent Pharmaceutical, LLC

Representatives

H. Dale Langley, Jr. The Law Firm Of H Dale Langley Jr P C

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

wholesale store services featuring pharmaceuticals

Publications

History of USPTO decisions and trademark events.

30 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

03/14/2026

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

08/10/2023

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

08/10/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/10/2023

ES8R

TEAS SECTION 8 RECEIVED

03/07/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/14/2022

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

03/14/2017

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/07/2017

ALIE

ASSIGNED TO LIE

01/13/2017

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

01/03/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/17/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/17/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/17/2016

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

05/19/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/18/2016

GNRT

NON-FINAL ACTION E-MAILED

05/18/2016

CNRT

NON-FINAL ACTION WRITTEN

05/18/2016

IUAA

USE AMENDMENT ACCEPTED

05/18/2016

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

05/07/2016

IUAF

USE AMENDMENT FILED

05/07/2016

EAAU

TEAS AMENDMENT OF USE RECEIVED

05/06/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/06/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/06/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/06/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/06/2015

GNRT

NON-FINAL ACTION E-MAILED

11/06/2015

CNRT

NON-FINAL ACTION WRITTEN

11/06/2015

DOCK

ASSIGNED TO EXAMINER

11/02/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/29/2015

NWAP

NEW APPLICATION ENTERED

07/25/2015

Continuous trademark protection

Get notified about every new filing that threatens INDEPENDENT PHARMACEUTICAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.